Alnylam Pharmaceuticals (ALNY) EPS (Basic) (2009 - 2026)
Alnylam Pharmaceuticals posted quarterly EPS (Basic) of $1.55 for Q1 2026, up 1207.14% year-on-year from $0.12 in Q1 2025, and up 84.52% on a QoQ basis from $0.84 in Q4 2025.
Alnylam Pharmaceuticals (ALNY) has 18 years of EPS (Basic) data on file, last reported at $1.55 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) rose 1207.14% year-over-year to $1.55; the trailing twelve-month figure through Mar 2026 stood at $3.79 (up 311.73% YoY), and the FY2025 full-year result was $2.39, up 209.63% from the prior year.
- EPS (Basic) for Q1 2026 stood at $1.55, up from $0.84 in the prior quarter.
- Across five years, EPS (Basic) topped out at $1.91 in Q3 2025 and bottomed at -$3.32 in Q3 2022.
- The 5-year median for EPS (Basic) is -$0.65 (2024), against an average of -$0.67.
- The widest annual swing landed in 2025, when EPS (Basic) sank 292.31%; it then jumped 1207.14% in 2026.
- A 5-year view of EPS (Basic) shows it stood at -$1.68 in 2022, then jumped by 35.12% to -$1.09 in 2023, then surged by 40.37% to -$0.65 in 2024, then jumped by 229.23% to $0.84 in 2025, then surged by 84.52% to $1.55 in 2026.
- The last three EPS (Basic) figures came in at $1.55 (Q1 2026), $0.84 (Q4 2025), and $1.91 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.06 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 4.06 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 6.99 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.55 |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -2.29 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.55 |
| Dec 31, 2025 | 0.84 |
| Sep 30, 2025 | 1.91 |
| Jun 30, 2025 | -0.51 |
| Mar 31, 2025 | -0.14 |
| Dec 31, 2024 | -0.65 |
| Sep 30, 2024 | -0.87 |
| Jun 30, 2024 | -0.13 |
| Mar 31, 2024 | -0.52 |
| Dec 31, 2023 | -1.09 |
| Sep 30, 2023 | 1.18 |
| Jun 30, 2023 | -2.21 |
| Mar 31, 2023 | -1.40 |
| Dec 31, 2022 | -1.68 |
| Sep 30, 2022 | -3.32 |
| Jun 30, 2022 | -2.29 |
| Mar 31, 2022 | -2.00 |
| Dec 31, 2021 | -2.16 |
| Sep 30, 2021 | -1.72 |
| Jun 30, 2021 | -1.61 |
| Mar 31, 2021 | -1.71 |
| Dec 31, 2020 | -2.09 |
| Sep 30, 2020 | -2.18 |
| Jun 30, 2020 | -1.56 |
| Mar 31, 2020 | -1.62 |
| Dec 31, 2019 | -2.47 |
| Sep 30, 2019 | -1.92 |
| Jun 30, 2019 | -2.02 |
| Mar 31, 2019 | -1.73 |
| Dec 31, 2018 | -2.09 |
| Sep 30, 2018 | -2.43 |
| Jun 30, 2018 | -1.63 |
| Mar 31, 2018 | -1.41 |
| Dec 31, 2017 | -1.48 |
| Sep 30, 2017 | -1.34 |
| Jun 30, 2017 | -1.34 |
| Mar 31, 2017 | -1.25 |
| Dec 31, 2016 | -1.32 |
| Sep 30, 2016 | -1.21 |
| Jun 30, 2016 | -1.05 |
| Mar 31, 2016 | -1.21 |
| Dec 31, 2015 | -1.07 |
| Sep 30, 2015 | -0.91 |
| Jun 30, 2015 | -0.85 |
| Mar 31, 2015 | -0.62 |
| Dec 31, 2014 | -0.28 |
| Sep 30, 2014 | -0.58 |
| Jun 30, 2014 | -0.58 |
| Mar 31, 2014 | -3.70 |
| Dec 31, 2013 | -0.51 |
| Sep 30, 2013 | -0.48 |
| Jun 30, 2013 | -0.29 |
| Mar 31, 2013 | -0.15 |
| Dec 31, 2012 | -1.20 |
| Sep 30, 2012 | -0.38 |
| Jun 30, 2012 | -0.25 |
| Mar 31, 2012 | -0.25 |
| Dec 31, 2011 | -0.33 |
| Sep 30, 2011 | -0.31 |
| Jun 30, 2011 | -0.33 |
| Mar 31, 2011 | -0.38 |
| Dec 31, 2010 | -0.17 |
| Sep 30, 2010 | -0.23 |
| Jun 30, 2010 | -0.35 |
| Dec 31, 2009 | -0.19 |